Cambridge, MA, United States of America

Altus Pharmaceuticals Inc.


USPTO Granted Patents = 4

% Expired Patents = 75.0



Forward Citations = 38

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Alexey L Margolin (3 out of 26 patents)

silverMedal Bhami Shenoy (2 out of 29 patents)

bronzeMedal Chandrika Govardhan (1 out of 10 patents)

4.  Nazar K Khalaf (1 out of 4 patents)

5.  Scott L Rakestraw (1 out of 4 patents)

6.  Nancy L St Clair (1 out of 4 patents)

7.  Sinikka Uotila (1 out of 5 patents)

8.  Kalevi Visuri (1 out of 5 patents)

9.  Wang Yi Fong (1 out of 2 patents)

10.  Yao Yiming (1 out of 2 patents)

11.  Margaret McGrath (1 out of 1 patent)

12.  Merrick R Almond (1 out of 19 patents)

13.  Danica Grujic (7 patents)

14.  Teresa G Cachero (7 patents)

15.  Lekai Zhang (5 patents)


4 patents:

Company Overview
Altus Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal and metabolic diseases. Their pipeline includes potential treatments for rare genetic disorders and chronic conditions such as pancreatic insufficiency. Altus is committed to improving patient outcomes through cutting-edge research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#411 in Cambridge, MA

#3,314 in Massachusetts

#60,671 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 38

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Altus Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/altus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…